semaglutide antibiotics with Active ingredient in Ozempic, Wegovy shows early promise for treating alcohol use disorder among those obesity: Study FBI warns about counterfeit weight – Glucagon-like peptide-1 (GLP-1) receptor agonists

Changes in insulin sensitivity may occur, potentially making weight control more challenging

R., Meira Filho, L

For example, the FDAs approval of Lillys ZepBound (tirzepatide for chronic weight management) in late 2023 was based on phase III data showing superior weight loss compared to placebo

Impact on Waist Circumference & Fat Distribution Research also shows that GLP-1 medications help reduce: Visceral fat (fat around the organs) Liver fat (in patients with fatty liver, NAFLD) Waist size and abdominal fat mass These improvements support cardiovascular health and metabolic stability, not just weight loss